Wockhardt Limited (WOCKPHARMA.NS)
INR 1310.1
(1.03%)
INR 1310.1
(1.03%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 7.72 Billion INR | -49.29% |
| 2022 | 15.4 Billion INR | -20.74% |
| 2021 | 19.43 Billion INR | 24.25% |
| 2020 | 15.63 Billion INR | -4.04% |
| 2019 | 16.29 Billion INR | -29.92% |
| 2018 | 23.25 Billion INR | 8.69% |
| 2017 | 21.39 Billion INR | -9.06% |
| 2016 | 23.52 Billion INR | -17.66% |
| 2015 | 28.57 Billion INR | -4.57% |
| 2014 | 29.94 Billion INR | -0.99% |
| 2013 | 30.24 Billion INR | -21.69% |
| 2012 | 38.61 Billion INR | 39.12% |
| 2011 | 27.75 Billion INR | 24.2% |
| 2010 | 22.35 Billion INR | -11.62% |
| 2009 | 25.28 Billion INR | 12.29% |
| 2008 | 22.52 Billion INR | 35.64% |
| 2007 | 16.6 Billion INR | 56.47% |
| 2006 | 10.61 Billion INR | 26.95% |
| 2005 | 8.35 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 2.12 Billion INR | 10.99% |
| 2023 Q1 | 3.62 Billion INR | -2.69% |
| 2023 Q2 | 4.66 Billion INR | 28.73% |
| 2023 FY | 7.81 Billion INR | -49.29% |
| 2023 Q4 | 1.91 Billion INR | -52.13% |
| 2023 Q3 | 3.99 Billion INR | -14.38% |
| 2022 Q3 | 3.79 Billion INR | -9.98% |
| 2022 Q4 | 3.72 Billion INR | -1.85% |
| 2022 FY | 15.4 Billion INR | -20.74% |
| 2022 Q1 | 3.68 Billion INR | 2.27% |
| 2022 Q2 | 4.21 Billion INR | 14.4% |
| 2021 Q2 | 5.25 Billion INR | -1.88% |
| 2021 Q4 | 3.59 Billion INR | -31.0% |
| 2021 FY | 19.43 Billion INR | 24.25% |
| 2021 Q1 | 5.35 Billion INR | 70.88% |
| 2021 Q3 | 5.21 Billion INR | -0.83% |
| 2020 Q1 | 3.79 Billion INR | 219.15% |
| 2020 FY | 15.63 Billion INR | -4.04% |
| 2020 Q4 | 3.13 Billion INR | -30.17% |
| 2020 Q3 | 4.49 Billion INR | 6.65% |
| 2020 Q2 | 4.21 Billion INR | 10.81% |
| 2019 Q1 | 5.1 Billion INR | -3.27% |
| 2019 Q3 | 5.19 Billion INR | 8.1% |
| 2019 Q4 | 1.19 Billion INR | -77.08% |
| 2019 FY | 16.29 Billion INR | -29.92% |
| 2019 Q2 | 4.8 Billion INR | -5.83% |
| 2018 Q3 | 5.81 Billion INR | -8.7% |
| 2018 FY | 23.25 Billion INR | 8.69% |
| 2018 Q4 | 5.27 Billion INR | -9.26% |
| 2018 Q1 | 5.79 Billion INR | 4.69% |
| 2018 Q2 | 6.36 Billion INR | 9.94% |
| 2017 FY | 21.39 Billion INR | -9.06% |
| 2017 Q3 | 5.57 Billion INR | 1.27% |
| 2017 Q4 | 5.53 Billion INR | -0.75% |
| 2017 Q2 | 5.5 Billion INR | 15.19% |
| 2017 Q1 | 4.77 Billion INR | 12.25% |
| 2016 Q2 | 6.72 Billion INR | 3.89% |
| 2016 Q4 | 4.25 Billion INR | -26.66% |
| 2016 Q3 | 5.8 Billion INR | -13.65% |
| 2016 FY | 23.52 Billion INR | -17.66% |
| 2016 Q1 | 6.47 Billion INR | 6.22% |
| 2015 Q2 | 8.16 Billion INR | 11.2% |
| 2015 Q1 | 7.33 Billion INR | -6.82% |
| 2015 FY | 28.57 Billion INR | -4.57% |
| 2015 Q4 | 6.09 Billion INR | -11.99% |
| 2015 Q3 | 6.92 Billion INR | -15.17% |
| 2014 Q4 | 7.87 Billion INR | -20.67% |
| 2014 Q3 | 9.92 Billion INR | 62.29% |
| 2014 FY | 29.94 Billion INR | -0.99% |
| 2014 Q2 | 6.11 Billion INR | 1.62% |
| 2014 Q1 | 6.01 Billion INR | -7.13% |
| 2013 Q1 | 8.96 Billion INR | -15.11% |
| 2013 Q3 | 7.75 Billion INR | 10.21% |
| 2013 FY | 30.24 Billion INR | -21.69% |
| 2013 Q4 | 6.48 Billion INR | -16.44% |
| 2013 Q2 | 7.03 Billion INR | -21.45% |
| 2012 Q3 | 10.13 Billion INR | 7.65% |
| 2012 Q2 | 9.41 Billion INR | 10.64% |
| 2012 Q1 | 8.51 Billion INR | 9.7% |
| 2012 FY | 38.61 Billion INR | 39.12% |
| 2012 Q4 | 10.55 Billion INR | 4.16% |
| 2011 Q4 | 7.75 Billion INR | 10.14% |
| 2011 FY | 27.75 Billion INR | 24.2% |
| 2011 Q3 | 7.04 Billion INR | 0.0% |
| 2010 FY | 22.35 Billion INR | -11.62% |
| 2009 FY | 25.28 Billion INR | 12.29% |
| 2008 FY | 22.52 Billion INR | 35.64% |
| 2007 FY | 16.6 Billion INR | 56.47% |
| 2006 FY | 10.61 Billion INR | 26.95% |
| 2005 FY | 8.35 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Sigachi Industries Limited | 2 Billion INR | -285.56% |
| Ind-Swift Limited | 2.17 Billion INR | -255.346% |
| Innova Captab Limited | 3.46 Billion INR | -122.835% |
| Aarti Drugs Limited | 8.31 Billion INR | 7.169% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -32.388% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -424.526% |
| Sakar Healthcare Limited | 699.58 Million INR | -1003.511% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 92.953% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 566.212% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -24.062% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -1016.909% |
| Morepen Laboratories Limited | 6.16 Billion INR | -25.299% |
| Sequent Scientific Limited | 2.97 Billion INR | -159.171% |
| Wanbury Limited | 1.73 Billion INR | -346.077% |
| Laurus Labs Limited | 15.44 Billion INR | 50.028% |
| Nectar Lifesciences Limited | 4.82 Billion INR | -60.057% |
| Gufic Biosciences Limited | 4.07 Billion INR | -89.507% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 37.907% |
| Alembic Limited | 1 Billion INR | -671.917% |
| Hikal Limited | 5.95 Billion INR | -29.574% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 71.173% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 88.867% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | -63.591% |
| Themis Medicare Limited | 2.42 Billion INR | -219.007% |
| RPG Life Sciences Limited | 2.48 Billion INR | -210.914% |
| Lupin Limited | 125.09 Billion INR | 93.829% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -268.666% |
| Vaishali Pharma Limited | 90.32 Million INR | -8447.103% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -1082.979% |
| NATCO Pharma Limited | 25.73 Billion INR | 70.003% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 60.698% |
| FDC Limited | 6.58 Billion INR | -17.215% |
| Divi's Laboratories Limited | 32.44 Billion INR | 76.202% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -1144.204% |
| Eris Lifesciences Limited | 10.42 Billion INR | 25.96% |
| Windlas Biotech Limited | 1.33 Billion INR | -476.636% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 97.013% |
| Mankind Pharma Limited | 42.19 Billion INR | 81.705% |
| Venus Remedies Limited | 2.18 Billion INR | -253.709% |
| ZIM Laboratories Limited | 1.26 Billion INR | -508.923% |
| Neuland Laboratories Limited | 8.24 Billion INR | 6.4% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | 49.407% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -309.144% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 93.834% |
| Bal Pharma Limited | 770.19 Million INR | -902.344% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 95.281% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -1358.982% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | 16.146% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -108.906% |
| Shilpa Medicare Limited | 3.56 Billion INR | -116.738% |
| Orchid Pharma Limited | 2.32 Billion INR | -232.715% |
| Albert David Limited | 1.4 Billion INR | -448.262% |
| Ajanta Pharma Limited | 21.06 Billion INR | 63.35% |
| Hester Biosciences Limited | 1.27 Billion INR | -506.132% |
| Valiant Laboratories Limited | 138.02 Million INR | -5493.028% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -87.23% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -33.532% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -6730.106% |
| Granules India Limited | 16.79 Billion INR | 54.046% |
| Alkem Laboratories Limited | 52.29 Billion INR | 85.238% |
| Medicamen Biotech Limited | 495.49 Million INR | -1458.038% |
| Unichem Laboratories Limited | 4.86 Billion INR | -58.687% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -1607.387% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -61438.462% |
| Medico Remedies Limited | 262.14 Million INR | -2844.946% |
| Ipca Laboratories Limited | 48.58 Billion INR | 84.11% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -1279.796% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | -86.779% |
| Brooks Laboratories Limited | 65.62 Million INR | -11664.706% |
| Piramal Enterprises Limited | 8.04 Billion INR | 4.019% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 83.489% |
| Suven Life Sciences Limited | -200.79 Million INR | 3944.679% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 7199.046% |
| Strides Pharma Science Limited | 14.38 Billion INR | 46.345% |
| Indoco Remedies Limited | 8.04 Billion INR | 4.016% |
| Alpa Laboratories Limited | 188.89 Million INR | -3986.927% |
| Lasa Supergenerics Limited | 121.02 Million INR | -6278.584% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -1874.091% |